Skip to main content

Mark Cuban Archives

Study finds Mark Cuban’s Cost Plus Drug Company could save taxpayers millions on Medicare generic oncology drugs

Jun. 8, 2023—Vanderbilt research finds that the U.S. government could save taxpayers between $228 million-$2.15 billion a year if insurers who operate its Medicare Part D plans purchased seven generic oncology drugs at the same prices obtained by the Mark Cuban Cost Plus Drug Company.

Read more

Miss the discussion with Mark Cuban? Watch the recording here.

Mar. 24, 2023—Last week, Vanderbilt University Medical Center hosted “A Discussion with Mark Cuban: How Cost Plus Drugs Is Innovating to Lower Prescription Drug Prices in America.” The event took place at Monroe Carell Jr. Children’s Hospital at Vanderbilt. Cuban was joined by Professor of Health Policy Stacie Dusetzina, PhD, and VUMC Urologic Oncology fellow Ruchika Talwar,...

Read more

Mark Cuban pharmacy could save billions on prostate cancer, bladder drugs

Feb. 9, 2023—Vanderbilt research found that a new drug company founded by entrepreneur Mark Cuban could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on just the nine most popular urological drugs.

Read more

Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
VUMC Voice